Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

More articles from psychopharmacology for the clinician

  • You have access
    Long-acting injectable antipsychotics: choosing the right dose
    David Carlone and Nicholas Delva
    J Psychiatry Neurosci July 01, 2020 45 (4) 298; DOI: https://doi.org/10.1503/jpn.200015
  • You have access
    Consensus statement on the use of clozapine during the COVID-19 pandemic
    Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler and Oliver Freudenreich
    J Psychiatry Neurosci May 01, 2020 45 (3) 222-223; DOI: https://doi.org/10.1503/jpn.200061
  • You have access
    Mu-opioid antagonism in the treatment of cannabis use disorder
    Oussama Kebir, Xavier Laqueille and Fayçal Mouaffak
    J Psychiatry Neurosci March 01, 2020 45 (2) 143-144; DOI: https://doi.org/10.1503/jpn.190182
  • You have access
    Kleptomania treated with naltrexone in a patient with intellectual disability
    Faycal Mouaffak, Sonia Hamzaoui, Oussama Kebir and Xavier Laqueille
    J Psychiatry Neurosci January 01, 2020 45 (1) 71-72; DOI: https://doi.org/10.1503/jpn.190064
  • You have access
    Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
    Nicolas Garel and Ridha Joober
    J Psychiatry Neurosci November 01, 2019 44 (6) E31-E32; DOI: https://doi.org/10.1503/jpn.190081
  • You have access
    Management of sexual adverse effects induced by atypical antipsychotic medication
    Laura Downing, David D. Kim, Ric M. Procyshyn and Philip Tibbo
    J Psychiatry Neurosci July 01, 2019 44 (4) 287-288; DOI: https://doi.org/10.1503/jpn.190053
  • You have access
    N-Acetylcysteine augmentation in refractory obsessive–compulsive disorder
    Sreenivasa Bhaskara
    J Psychiatry Neurosci May 01, 2019 44 (3) 215-216; DOI: https://doi.org/10.1503/jpn.180179
  • You have access
    Treating resistant depression with 2 forms of convulsive therapy: a clinical case study
    Anastasios A. Daskalakis and Zafiris J. Daskalakis
    J Psychiatry Neurosci March 01, 2019 44 (2) 143-144; DOI: https://doi.org/10.1503/jpn.180141
  • You have access
    Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment
    David D. Kim, Alasdair M. Barr, Randall F. White, William G. Honer and Ric M. Procyshyn
    J Psychiatry Neurosci January 01, 2019 44 (1) 71-72; DOI: https://doi.org/10.1503/jpn.180087
  • You have access
    Tic-related obsessive–compulsive disorder
    Tamara Pringsheim and John Piacentini
    J Psychiatry Neurosci November 01, 2018 43 (6) 431-432; DOI: https://doi.org/10.1503/jpn.180086

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. Print ISSN 1180-4882; Online ISSN 1488-2434.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

Powered by HighWire